News

01
December

Huff Post conversation with MYOS Chairman Dr. Robert Hariri

Written by Robin L. Smith Originally published in Huffington Post Science Bob Hariri, M.D., Ph.D., is the vice chairman of Human Longevity Inc. (HLI), a genomics and cell-therapy diagnostics and therapeutics company he co-founded in 2013 with Craig Venter and Peter Diamandis, which is focused on extending the healthy, high-performance human lifespan. Utilizing technological advancements in

18
July

BioWorld: "Myos, Cloud collaborate to 'muscle in' on new therapeutic category"

Originally published in BioWorld™ Today, Volume 25, No. 138Written by Marie Powers, BioWorld Staff Writer Myos Corp., which is taking a bifurcated approach in developing products to improve muscle mass, increase mobility and reduce frailty, is going to the "cloud" through a research and development agreement with newco Cloud Pharmaceuticals Inc. Although terms were not disclosed, the

17
July

"Contact Light" - A Tribute To MYOS Board Member, Dr. Buzz Aldrin

"Contact light." Those were the first words uttered by a human after Apollo 11 landed on the moon. It was 45 years ago today that Apollo 11 started it's journey to the moon and back. Buzz Aldrin was the lunar module pilot who made that statement. "Contact light" referred to a light inside the Apollo 11 landing module (The Eagle) that flickered as a probe at the bottom of the spacecraft touched

14
July

Biotech Visionaries Venter, Hariri and Diamandis Unite on MYOS Board of Directors

MYOS Corporation announced today that it has appointed genomic pioneer, J. Craig Venter, Ph.D. to its Board of Directors. The “three musketeers of innovation,” J. Craig Venter, Ph.D., Robert J. Hariri, M.D., Ph.D. and Peter Diamandis, M.D. have united prior to MYOS as co-founders of Human Longevity, Inc., a genomics and cell therapy-based diagnostic and therapeutic company. Now,

26
June

Scientific American worldVIEW Includes MYOS Sponsor Feature "Staying Strong"

We are excited to sponsor the 2014 edition of Scientific American worldVIEW: A Global Biotechnology Perspective, which was unveiled this week at the 2014 BIO International Conference in San Diego, California. Sarcopenia and the importance of muscle health are the key topics in the MYOS Corporation sponsor feature, "Staying Strong," included on pages 8-9 of the issue and also available online

26
June

MYOS Chairman Robert Hariri to speak at 2014 BIO Convention During Scientific American Super Session

MYOS Chairman Dr. Robert Hariri will be speaking during the Scientific American WorldView Super Session—Biotech: We are the World-today—at the BIO International Convention in San Diego, California. This event will explore key themes from Scientific American's annual biotechnology edition, featuring the worldVIEW Scorecard and fresh perspectives on international life science

13
June

Letterman's Doctor and MYOS Board Member Dr. Louis Aronne Saves Parking Attendant who Suffered Stroke

MYOS board member and David Letterman's doctor Dr. Louis Aronne recently saved the life of a Manhattan parking attendant who suffered a stroke. Read the full feature from the New York Post below and join us in applauding Dr. Aronne's efforts. Letterman’s doctor saves parking attendant who suffered strokeOriginally published by the New York Post - June 12, 2014By Amber Sutherland and Danika

14
March

Robert Hariri, MD, PhD: "We need heroes to help dying patients."

As thousands joined the fight over the past few weeks to save Josh Hardy’s life by lobbying drug company Chimerix to allow the dying boy access to its potentially life-saving treatment, supporters finally received the news they’d been hoping for on Tuesday evening. In a statement late in the day, Chimerix CEO Kenneth I. Moch confirmed that the FDA had approved an